Pediatric Hemato-Oncology

Immunotherapy in pediatric hemato - oncology

Stem Cells in Hemato-Oncology

Clinical features and complications of viridans streptococci bloodstream infection in pediatric hemato-oncology patients.

BACKGROUND AND PURPOSE Viridans streptococci (VS) are part of the normal flora of humans, but are fast emerging as pathogens causing bacteremia in neutropenic patients. The clinical features, outcomes, and antibiotic susceptibilities of VS bloodstream infections in children with hemato-oncological diseases are reported in this study. METHODS A retrospective chart review of pediatric patients ...

The critically-ill pediatric hemato-oncology patient: epidemiology, management, and strategy of transfer to the pediatric intensive care unit

Cancer is a leading cause of death in children. In the past decades, there has been a marked increase in overall survival of children with cancer. However, children whose treatment includes hematopoietic stem cell transplantation still represent a subpopulation with a higher risk of mortality. These improvements in mortality are accompanied by an increase in complications, such as respiratory a...

Invasive Aspergillosis in Pediatric Hematology Oncology Ward

Background: Patients with prolonged neutropenia and/or severe underlying immunosuppression are at thegreatest risk for disseminated aspergillosis. This study was undertaken to determine the incidence of invasiveaspergillosis by Platelia Aspergillus enzyme-linked immunosorbent assay ELISA kit in high risk children admitted tothe hematology ward of Dr. Faghihi hospital, Shiraz University of Medic...